CN Stock MarketDetailed Quotes
600518 Kangmei Pharmaceutical
- 2.58
- -0.01-0.39%
Not Open Dec 19 15:00 CST
35.77BMarket Cap143.33P/E (TTM)
2.61High2.54Low3.26MlotVolume2.57Open2.59Pre Close835.88MTurnover2.39%Turnover Ratio368.57P/E (Static)13.86BShares2.9552wk High5.08P/B35.12BFloat Cap1.6852wk Low2.85Limit Up13.61BShs Float26.28Historical High2.33Limit Down2.70%Amplitude0.00Historical Low--Dividend TTM2.57Avg Price1.66MlotAsk--Div YieldTTM100Lot Size1.55MlotBid
Kangmei Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -8.44%3.62B | -17.85%2.37B | -22.69%1.08B | 35.25%5.26B | 45.30%3.95B | 69.04%2.88B | 75.09%1.4B | -17.63%3.89B | -19.22%2.72B | -25.60%1.71B |
| Refunds of taxes and levies | -94.38%321.32K | -94.89%291.75K | -99.20%24.38K | -79.58%5.83M | -82.59%5.71M | -67.35%5.71M | --3.06M | 2,043.98%28.54M | 1,255.44%32.81M | 660.63%17.49M |
| Cash received relating to other operating activities | -33.70%90.24M | 27.80%50.51M | -64.64%20.76M | -65.02%143.08M | -0.12%136.11M | -59.45%39.52M | 24.71%58.69M | -56.59%408.99M | -34.48%136.27M | -42.52%97.46M |
| Cash inflows from operating activities | -9.40%3.71B | -17.38%2.42B | -24.53%1.11B | 25.02%5.41B | 41.71%4.09B | 60.86%2.93B | 72.66%1.46B | -23.63%4.33B | -19.24%2.89B | -26.12%1.82B |
| Goods services cash paid | -9.50%2.98B | -19.44%1.96B | -25.31%980.67M | 19.46%4.22B | 50.38%3.29B | 70.45%2.43B | 74.79%1.31B | -11.73%3.53B | -5.71%2.19B | -4.44%1.43B |
| Staff behalf paid | 4.91%550.44M | 5.88%363.38M | 5.27%182.74M | 5.20%716.48M | 6.86%524.7M | 7.32%343.21M | 9.06%173.58M | 9.26%681.04M | 4.58%491.01M | -3.00%319.81M |
| All taxes paid | 44.22%243.37M | 62.49%219.73M | 280.24%189.9M | -30.61%217.19M | -29.56%168.75M | -34.05%135.23M | 55.88%49.94M | 32.27%313M | 24.66%239.57M | 36.32%205.06M |
| Cash paid relating to other operating activities | -20.89%288.6M | -6.06%198.2M | -35.64%84.5M | 4.21%574.6M | 18.35%364.83M | 12.63%210.99M | 24.63%131.29M | -6.62%551.41M | -36.76%308.26M | -44.03%187.32M |
| Cash outflows from operating activities | -6.64%4.06B | -12.20%2.74B | -13.79%1.44B | 12.80%5.73B | 34.75%4.35B | 45.92%3.12B | 59.18%1.67B | -6.87%5.08B | -7.00%3.23B | -7.32%2.14B |
| Net cash flows from operating activities | -38.05%-349.69M | -67.66%-318.86M | -63.64%-332.56M | 57.66%-317.52M | 24.83%-253.31M | 39.96%-190.18M | -1.87%-203.22M | -450.11%-749.96M | -410.31%-336.96M | -300.15%-316.75M |
| Investing cash flow | ||||||||||
| Cash received from returns on investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,401.94%547.61K | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 29.79%55.51M | 10.77%46.98M | -16.89%35.13M | 3,271.93%52.25M | 4,295.41%42.77M | 11,750.03%42.41M | 12,064.38%42.27M | -98.01%1.55M | -99.59%973.06K | -99.85%357.91K |
| Net cash received from disposal of subsidiaries and other business units | --7.5M | --7.5M | --7.5M | --9.85M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 47.33%63.01M | 28.45%54.48M | 0.85%42.63M | 2,861.35%62.1M | 4,295.41%42.77M | 11,750.03%42.41M | 12,064.38%42.27M | -98.45%2.1M | -99.91%973.06K | -99.97%357.91K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -22.67%37.21M | -31.61%26.57M | -48.98%14.41M | 107.29%99.74M | 250.25%48.12M | 644.78%38.86M | 1,760.14%28.25M | -71.96%48.12M | -86.12%13.74M | -92.71%5.22M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | --145.19K | --145.19K | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -22.90%37.21M | -31.87%26.57M | -48.98%14.41M | 107.29%99.74M | 251.31%48.27M | 647.56%39M | 1,760.14%28.25M | -72.05%48.12M | -86.12%13.74M | -92.71%5.22M |
| Net cash flows from investing activities | 569.32%25.8M | 718.42%27.91M | 101.33%28.21M | 18.21%-37.64M | 56.94%-5.5M | 170.17%3.41M | 1,296.28%14.01M | -26.05%-46.02M | -101.31%-12.77M | -100.48%-4.86M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --945K | --500K | --300K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --945K | --500K | --300K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | -91.88%3.72M | ---- | 155.12%27.46M | 301.03%72.6M | --45.8M | --37.53M | --10.76M | --18.1M | ---- | ---- |
| Cash inflows from financing activities | -89.81%4.66M | -98.67%500K | 157.90%27.76M | 301.03%72.6M | --45.8M | --37.53M | --10.76M | -99.06%18.1M | ---- | ---- |
| Dividend interest payment | --400K | ---- | ---- | ---- | ---- | ---- | ---- | -93.51%896.85K | -97.70%725.62K | -99.87%40.73K |
| -Including:Cash payments for dividends or profit to minority shareholders | --400K | ---- | ---- | ---- | ---- | ---- | ---- | --856.11K | ---- | ---- |
| Cash payments relating to other financing activities | -68.45%40.31M | -74.46%22.4M | -12.77%36.71M | 44.29%193.45M | 132.61%127.77M | 197.33%87.69M | 304.03%42.08M | 175.52%134.07M | 97.56%54.93M | 87.29%29.49M |
| Cash outflows from financing activities | -68.14%40.71M | -74.46%22.4M | -12.77%36.71M | 43.33%193.45M | 129.57%127.77M | 196.92%87.69M | 302.46%42.08M | -15.39%134.96M | -94.49%55.66M | -97.04%29.53M |
| Net cash flows from financing activities | 56.03%-36.05M | 56.35%-21.9M | 71.43%-8.95M | -3.41%-120.85M | -47.29%-81.98M | -69.84%-50.16M | -199.51%-31.32M | -106.61%-116.86M | 93.92%-55.66M | 96.82%-29.53M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -137.80%-2.21K | -138.48%-1.62K | -45.22%-1.1K | 27.80%2.82K | 98.96%5.84K | 66.21%4.2K | ---754.55 | 105.90%2.21K | -83.54%2.94K | -90.90%2.53K |
| Net increase in cash and cash equivalents | -5.62%-359.94M | -32.05%-312.85M | -42.06%-313.29M | 47.85%-476.01M | 15.94%-340.78M | 32.53%-236.92M | -4.46%-220.53M | -146.91%-912.84M | -339.08%-405.38M | -251.10%-351.14M |
| Add:Begin period cash and cash equivalents | -33.24%955.89M | -33.24%955.89M | -33.24%955.89M | -38.93%1.43B | -38.93%1.43B | -38.93%1.43B | -38.93%1.43B | 488.09%2.34B | 488.09%2.34B | 488.09%2.34B |
| End period cash equivalent | -45.38%595.95M | -46.19%643.04M | -46.95%642.59M | -33.24%955.89M | -43.74%1.09B | -40.06%1.19B | -43.22%1.21B | -38.93%1.43B | 241.28%1.94B | 215.90%1.99B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
